The National Institute for Health and Clinical Excellence (NICE) in Britain has approved two new drugs for treating skin cancer after the manufacturers agreed to supply the drugs to the NHS at reduced costs. The drugs, ipilimumab and vemurafenib, are manufactured by Bristol-Myers Squibb and Roche respectively. Nice had initially decided not to recommend the drugs for NHS due to high costs but was swayed into recommending them after the manufacturers agreed on an undisclosed ...Saturday, 3 November 2012
NICE Approves Two New Skin Cancer Drugs
The National Institute for Health and Clinical Excellence (NICE) in Britain has approved two new drugs for treating skin cancer after the manufacturers agreed to supply the drugs to the NHS at reduced costs. The drugs, ipilimumab and vemurafenib, are manufactured by Bristol-Myers Squibb and Roche respectively. Nice had initially decided not to recommend the drugs for NHS due to high costs but was swayed into recommending them after the manufacturers agreed on an undisclosed ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment